K. Peony Yu

2014

In 2014, K. Peony Yu earned a total compensation of $3M as Chief Medical Officer at FibroGen, a 299% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$464,328
Option Awards$1,577,772
Salary$428,655
Stock Awards$504,000
Other$16,290
Total$2,991,045

Yu received $1.6M in option awards, accounting for 53% of the total pay in 2014.

Yu also received $464.3K in non-equity incentive plan, $428.7K in salary, $504K in stock awards and $16.3K in other compensation.

Rankings

In 2014, K. Peony Yu's compensation ranked 3,042nd out of 13,032 executives tracked by ExecPay. In other words, Yu earned more than 76.7% of executives.

ClassificationRankingPercentile
All
3,042
out of 13,032
77th
Division
Manufacturing
1,078
out of 4,965
78th
Major group
Chemicals And Allied Products
345
out of 1,690
80th
Industry group
Drugs
269
out of 1,369
80th
Industry
Pharmaceutical Preparations
220
out of 1,042
79th
Source: SEC filing on April 24, 2017.

Yu's colleagues

We found three more compensation records of executives who worked with K. Peony Yu at FibroGen in 2014.

2014

Thomas Neff

FibroGen

Chief Executive Officer

2014

Frank Valone

FibroGen

Chief Medical Officer

2014

Pat Cotroneo

FibroGen

Chief Financial Officer

News

In-depth

You may also like